Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SITAGLIPTIN for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where SITAGLIPTIN was used for Ill-defined disorder.

Most Reported Side Effects for SITAGLIPTIN

Side Effect Reports % Deaths Hosp.
Blood glucose increased 1,427 7.2% 40 241
Pancreatic carcinoma 1,142 5.7% 725 361
Product dose omission issue 1,125 5.7% 1 88
Drug ineffective 1,057 5.3% 69 202
No adverse event 994 5.0% 0 4
Nausea 936 4.7% 81 484
Pancreatitis 922 4.6% 177 507
Diabetes mellitus inadequate control 744 3.7% 110 260
Diarrhoea 712 3.6% 83 224
Hypoglycaemia 674 3.4% 109 447
Death 654 3.3% 653 241
Headache 620 3.1% 57 242
Acute kidney injury 589 3.0% 141 456
Fatigue 573 2.9% 49 306
Vomiting 564 2.8% 70 354

Other Indications for SITAGLIPTIN

Type 2 diabetes mellitus (6,353) Diabetes mellitus (4,792) Product used for unknown indication (2,161) Blood glucose increased (126) Blood glucose abnormal (114) Diabetes mellitus management (86) Blood glucose (81) Insulin-requiring type 2 diabetes mellitus (57) Type 1 diabetes mellitus (47) Glycosylated haemoglobin increased (41)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

SITAGLIPTIN Full Profile All Ill-defined disorder Drugs SITAGLIPTIN Demographics SITAGLIPTIN Timeline